A Study of Tirzepatide (LY3298176) in Pediatric Participants With Obesity
Clinical trial NCT05696847 · COMPLETED
Trial details
- NCT number
- NCT05696847
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-07
- Primary completion
- 2025-01-16
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.